CompletedNCT00496925
Dopamine-blocking medicines for OCD
About this title
Read the official source — NCT00496925Observational studyAges 18+Israel
Understand this study
Who was this study for?
This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Ramat GanSee all locations and recruitment
Study information
Study start dateNovember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 63
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- Over 18 Years
- Official registry ID
- NCT00496925
- Official title
Show the full official title
Examining the Usage of Dopamine Blockers in OCD Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ramat Gan
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sheba Medical Center, a hospital or academic medical center.
Who was this study for?
This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.
